Treatment of Moderate FMR During AVR
Surgical Treatment of Aortic Valve Disease With Moderate Functional Mitral Regurgitation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Study Type
Study Type
Enrollment (Anticipated)
Enrollment
Contacts and Locations
Study Contact
Study Contact
- Name: Xieraili Tiemuerniyazi
- Phone Number: +86-18814115887
- Email: tiemuernyz@mail2.sysu.edu.cn
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Patients who received AVR (with or without concomitant MVr) from two center (Fuwai Yunnan Cardiovascular Hospital and Fuwai Hospital, Chinese Academy of Medical Sciences).
- Age more than 18 years.
Exclusion Criteria:
- Those with a history of rheumatic valvular disease or infective endocarditis.
- Primary mitral valve lesions.
- Patients receiving mitral valve replacement.
- Patient who refuse to participate in this study, or cannot complete 6-month follow-up after surgery.
- Age < 18 years.
Study Plan
How is the study designed?
Design Details
Number of groups / cohorts
Cohorts and Interventions
Group / CohortGroup / Cohort |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
isolated aortic valve replacement group
Isolated aortic valve replacement surgery.
|
Repair of mitral valve concomitant to aortic valve replacement.
|
|
aortic valve replacement with mitral valve repair group
Aortic valve replacement with mitral valve repair
|
Repair of mitral valve concomitant to aortic valve replacement.
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
left ventricular global longitudinal strain
Time Frame: 10/10/2022-10/10/2023
|
The change of left ventricular global longitudinal strain compared to before surgery
|
10/10/2022-10/10/2023
|
Collaborators and Investigators
Sponsor
Sponsor
Study record dates
Study Major Dates
Study Start (ANTICIPATED)
Study Start
Primary Completion (ANTICIPATED)
Primary Completion
Study Completion (ANTICIPATED)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (ACTUAL)
First Posted
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- FZX2019-06-01 2022YFKY088
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.